Omori Nariko, Omori Kazue, Takano Kazue
Department of Medicine II, Tokyo Women's Medical University, Tokyo, Japan.
Endocr J. 2008 Jul;55(3):583-8. doi: 10.1507/endocrj.k07e-163. Epub 2008 May 20.
We aimed to determine whether ultrasonography is a useful diagnostic tool by correlating its findings with biological data of patients with subacute thyroiditis (SAT). Thirty-two SAT patients were evaluated in a retrospective study. Thirty-one patients (96.9%) had tenderness, 14 (43.8%) had localized pain, and 11 patients (34.4%) had radiating pain during a state of SAT. With ultrasonography, we found 51 hypoechoic areas in 32 patients. The hypoechoic volume per unilateral thyroid gland (%) was significantly larger in areas accompanied with pain (P<0.001). Out of 27 patients measured, 18 (67%) were positive for thyroglobulin antibodies (TgAb), of whom all were females. TgAb levels ranged from 0.3 to 13.8 U/ml. During therapy, TgAb levels gradually increased in 2 of the 7 patients who were measured several times. Both thyroglobulin antigen (TgAg) and free thyroxine (FT4) correlated well with total hypoechoic volume (cm (3) ), and the TgAg level showed a strong correlation with the FT4 level (r = 0.7; P<0.0001). The area (%) that the hypoechoic volume occupied in the total thyroid gland, even if the area was over half, was not related to the need of L-T4 replacement therapy. Also, none of the other variables (age, days from onset until diagnosis, serum levels of FT4, TgAg, CRP, autoantibodies, therapies, treatment) differed between the patients with and without replacement therapy. In summary, we found that the hypoechoic area in patients with SAT reflected the degree of inflammation and thyroid hormone levels, though it was difficult to predict continuous hypothyroidism.
我们旨在通过将超声检查结果与亚急性甲状腺炎(SAT)患者的生物学数据相关联,来确定超声检查是否为一种有用的诊断工具。在一项回顾性研究中,对32例SAT患者进行了评估。31例患者(96.9%)有压痛,14例(43.8%)有局部疼痛,11例患者(34.4%)在SAT状态时有放射性疼痛。通过超声检查,我们在32例患者中发现了51个低回声区。单侧甲状腺低回声体积百分比在伴有疼痛的区域显著更大(P<0.001)。在27例接受测量的患者中,18例(67%)甲状腺球蛋白抗体(TgAb)呈阳性,其中均为女性。TgAb水平范围为0.3至13.8 U/ml。在治疗期间,7例多次测量的患者中有2例的TgAb水平逐渐升高。甲状腺球蛋白抗原(TgAg)和游离甲状腺素(FT4)均与总低回声体积(cm³)密切相关,且TgAg水平与FT4水平呈强相关(r = 0.7;P<0.0001)。低回声体积在整个甲状腺中所占的面积百分比,即使该面积超过一半,也与左甲状腺素(L-T4)替代治疗的需求无关。此外,在接受和未接受替代治疗的患者之间,其他变量(年龄、从发病到诊断的天数、FT4、TgAg、CRP、自身抗体、治疗方法、治疗)均无差异。总之,我们发现SAT患者的低回声区反映了炎症程度和甲状腺激素水平,尽管难以预测持续性甲状腺功能减退。